KURA ONCOLOGY ($KURA) posted quarterly earnings results for Q2 2026 on Wednesday, August 12th. The company reported earnings of -$0.77 per share, beating estimates of -$0.90 by $0.13. The company also reported revenue of $20,870,000, missing estimates of $21,847,961 by $-977,961.
You can see Quiver Quantitative's $KURA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KURA ONCOLOGY Insider Trading Activity
KURA ONCOLOGY insiders have traded $KURA stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $KURA stock by insiders over the last 6 months:
- MOLLIE LEONI (Chief Medical Officer) sold 84,929 shares for an estimated $834,283
- TERESA BROPHY BAIR (Chief Legal Officer) sold 2,256 shares for an estimated $21,160
- KATHLEEN FORD (Chief Operating Officer) sold 2,257 shares for an estimated $20,482
- BRIAN T. POWL (Chief Commercial Officer) sold 339 shares for an estimated $3,122
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
KURA ONCOLOGY Hedge Fund Activity
We have seen 108 institutional investors add shares of KURA ONCOLOGY stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEEP TRACK CAPITAL, LP added 2,643,542 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,491,996
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 1,420,102 shares (-70.2%) from their portfolio in Q1 2026, for an estimated $11,545,429
- ARMISTICE CAPITAL, LLC removed 1,200,000 shares (-24.3%) from their portfolio in Q1 2026, for an estimated $9,756,000
- AQR CAPITAL MANAGEMENT LLC removed 937,732 shares (-30.6%) from their portfolio in Q1 2026, for an estimated $7,623,761
- BLACKROCK, INC. added 871,702 shares (+9.0%) to their portfolio in Q2 2026, for an estimated $9,562,570
- PROSIGHT MANAGEMENT, LP added 827,100 shares (+32.7%) to their portfolio in Q1 2026, for an estimated $6,724,323
- STATE STREET CORP added 817,317 shares (+18.1%) to their portfolio in Q2 2026, for an estimated $8,965,967
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
KURA ONCOLOGY Price Targets
Multiple analysts have issued price targets for $KURA recently. We have seen 5 analysts offer price targets for $KURA in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Reni J. Benjamin from Citizens set a target price of $24.0 on 06/15/2026
- Daniel Brims from Lake Street set a target price of $23.0 on 04/14/2026
- Mara Goldstein from Mizuho set a target price of $25.0 on 03/24/2026
- David Dai from UBS set a target price of $15.0 on 03/13/2026
- Robert Driscoll from Wedbush set a target price of $36.0 on 03/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
